Results 181 to 190 of about 6,415,892 (312)
Oculomotor behaviour changes in patients with Parkinson’s disease (PD) are a promising source of prodromal disease markers. Capitalizing on this phenomenon to facilitate early diagnosis requires oculomotor assessment in prodromal cohorts.
Heidi C. Riek +14 more
doaj +1 more source
Table S4. Top 15 statistically significant GO processes relevant to the top 50 predicted target genes of hsa-miR-24-3p. (DOCX 18 kb)
Uwatoko, Hisashi +7 more
openaire +1 more source
Magnetoelectric nanoparticles (MENPs) enable fully wireless, minutely invasive neuromodulation, and potentially neural recording, by converting magnetic into electric and, conversely, electric into magnetic fields, respectively, at high spatiotemporal resolution.
Elric Zhang +14 more
wiley +1 more source
Reactive astrocytes mediate toxicity in iPSC derived dopaminergic neurons
Neuroinflammation is a hallmark of Parkinson’s disease (PD), a progressive neurodegenerative disorder characterized by the accumulation of α-synuclein and the death of dopaminergic neurons in the substantia nigra.
Naroa Ibarra-Aizpurua +6 more
doaj +1 more source
Molecular editing of bilobalide uncovers BB56, a PREP‐engaging chemotype with enhanced anti‐inflammatory activity in microglia. Integrated CETSA‐MS, SAR, and pathway analyses link BB56 to attenuation of p38 MAPK/NF‐κB and NLRP3‐associated inflammatory signaling, highlighting bilobalide editing as a strategy for developing neuroinflammation‐modulating ...
Chanin Sillapachaiyaporn +20 more
wiley +1 more source
Epidemiology of Tourette Syndrome
Background/Objectives: Tourette syndrome (TS) is a neurodevelopmental disorder, manifested by tics and a variety of behavioral comorbidities that cluster strongly within families, suggesting a combination of genetic and environmental risk factors.
Abdullah Yasir Yilmaz, Joseph Jankovic
doaj +1 more source
Pathological Phenotypes in Parkinson’s Disease: From Biomarkers to Treatments [PDF]
openThis paper discusses what Parkinson’s Disease (PD) is, highlighting its motor and non-motor symptoms, the current diagnostic and treatment approaches, and the importance of the identification of reliable biomarkers for PD.
DUARTE BASSO, CAMILA
core
Neuropsychological testing in Parkinson’s disease patients.
Neuropsychological testing in Parkinson’s disease patients.
Fengtao Liu (2605819) +11 more
core +1 more source
Using single‐cell transcriptomic and epigenomic profiling, researchers mapped microglial dysfunction across the lifespan of db/db mice. The authors uncovered a nonlinear microglial remodeling featuring early inflammatory priming, a mid‐stage transcriptional inflection, and late dysfunction.
Jizhou Zhang +6 more
wiley +1 more source
Magnetomechanical neuromodulation using magnetic nanodiscs enables remote activation of neurons. In a hemiparkinsonian mouse model, alternating magnetic fields actuate the nanodiscs to generate torque that opens mechanosensitive ion channels within the subthalamic nucleus, thereby modulating basal ganglia motor circuitry.
Anouk Wolters +12 more
wiley +1 more source

